Acrodermatitis Continua of Hallopeau and Generalised Pustular Psoriasis: Case Reports of Two Different Manifestations of IL36RN Mutation in Siblings
Mengjiao Gu,1,2,* Hanjing Huang,1,2,* Zhanshuo Xiao,3,* Fanzhang Meng,4 Han Sheng,4 Zhimin Lin,5 Chen Li,6,7 Yuanhao Wu1,2 1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 2National Clinical Research Center f...
| Published in: | Psoriasis: Targets and Therapy |
|---|---|
| Main Authors: | Gu M, Huang H, Xiao Z, Meng F, Sheng H, Lin Z, Li C, Wu Y |
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Subjects: | |
| Online Access: | https://www.dovepress.com/acrodermatitis-continua-of-hallopeau-and-generalised-pustular-psoriasi-peer-reviewed-fulltext-article-PTT |
Similar Items
Case report: Successful treatment with spesolimab of acrodermatitis continua of Hallopeau in an older patient without IL36RN mutations
by: Jianfeng Zheng, et al.
Published: (2025-01-01)
by: Jianfeng Zheng, et al.
Published: (2025-01-01)
Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report
by: Pengfei Wen, et al.
Published: (2024-02-01)
by: Pengfei Wen, et al.
Published: (2024-02-01)
Spesolimab in generalized pustular psoriasis complicated by acrodermatitis continua of Hallopeau: a case report and mechanistic insights
by: Xin-Yi Hou, et al.
Published: (2025-05-01)
by: Xin-Yi Hou, et al.
Published: (2025-05-01)
Long-term control of refractory acrodermatitis continua of Hallopeau with subcutaneous spesolimab: A case report
by: Jan Nicolai Wagner, MD, et al.
Published: (2025-12-01)
by: Jan Nicolai Wagner, MD, et al.
Published: (2025-12-01)
Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report
by: May Alorainy, et al.
Published: (2017-12-01)
by: May Alorainy, et al.
Published: (2017-12-01)
Acrodermatitis continua of hallopeau: aggravating factors and treatment outcomes of 96 patients
by: Liyan Yuan, et al.
Published: (2024-12-01)
by: Liyan Yuan, et al.
Published: (2024-12-01)
Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab
by: Luigi Gargiulo, et al.
Published: (2023-04-01)
by: Luigi Gargiulo, et al.
Published: (2023-04-01)
Apremilast Coadministered with Secukinumab for Effective Treatment of Acrodermatitis Continua of Hallopeau: A Case Report
by: Yao XY, et al.
Published: (2025-05-01)
by: Yao XY, et al.
Published: (2025-05-01)
Acrodermatitis continua of Hallopeau: a review and update on biological and small molecule targeted immunomodulatory therapies
by: Qiong Sun, et al.
Published: (2025-08-01)
by: Qiong Sun, et al.
Published: (2025-08-01)
Pustular Psoriasis: From Pathophysiology to Treatment
by: Giovanni Genovese, et al.
Published: (2021-11-01)
by: Giovanni Genovese, et al.
Published: (2021-11-01)
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study
by: Paolo Gisondi, et al.
Published: (2022-07-01)
by: Paolo Gisondi, et al.
Published: (2022-07-01)
Acrodermatitis continua of Hallopeau with psoriatic arthritis treated with biologics and apremilast
by: Shohei Igari, et al.
Published: (2023-09-01)
by: Shohei Igari, et al.
Published: (2023-09-01)
Acrodermatitis Continua of Hallopeau Successfully Treated With Bimekizumab
by: Andrea Pagliara, et al.
Published: (2024-10-01)
by: Andrea Pagliara, et al.
Published: (2024-10-01)
IL-36RN gene: key insights into its role in pediatric pustular psoriasis pathogenesis and treatment
by: Ye Wang, et al.
Published: (2025-03-01)
by: Ye Wang, et al.
Published: (2025-03-01)
Spesolimab Treatment in GPP: Impact of IL-36RN Mutations and Concomitant Plaque Psoriasis
by: Li W, et al.
Published: (2025-08-01)
by: Li W, et al.
Published: (2025-08-01)
The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab
by: Jason E. Hawkes, et al.
Published: (2023-11-01)
by: Jason E. Hawkes, et al.
Published: (2023-11-01)
Acrodermatitis continua de Hallopeau autolimitada en un paciente con pancreatitis crónica: un reporte de caso
by: Valeria Sofia Soto Ariño, et al.
Published: (2025-04-01)
by: Valeria Sofia Soto Ariño, et al.
Published: (2025-04-01)
Case report: Infantile generalized pustular psoriasis with IL36RN and CARD14 gene mutations
by: Xinyun Tong, et al.
Published: (2023-01-01)
by: Xinyun Tong, et al.
Published: (2023-01-01)
Pustular psoriasis of pregnancy with acrodermatitis continua of hallopeau
by: Akanksha Shah, et al.
Published: (2016-01-01)
by: Akanksha Shah, et al.
Published: (2016-01-01)
Pemphigus vegetans of hallopeau
by: Nanda Soni, et al.
Published: (2005-01-01)
by: Nanda Soni, et al.
Published: (2005-01-01)
Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review
by: Shi L, et al.
Published: (2023-04-01)
by: Shi L, et al.
Published: (2023-04-01)
Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID‐19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin
by: Samotij D, et al.
Published: (2021-04-01)
by: Samotij D, et al.
Published: (2021-04-01)
Knowledge Mapping and Research Hotspots of Generalized Pustular Psoriasis: A Bibliometric Analysis from 2003 to 2023
by: Wei L, et al.
Published: (2023-12-01)
by: Wei L, et al.
Published: (2023-12-01)
Achieving Therapeutic Success with Spesolimab: Two Cases of Drug-Induced Generalized Pustular Psoriasis Initially Mimicking Acute Generalized Exanthematous Pustulosis
by: Chen J, et al.
Published: (2025-07-01)
by: Chen J, et al.
Published: (2025-07-01)
Dermoscopy of acrodermatitis continua of Hallopeau
by: Setu Mittal, et al.
Published: (2023-01-01)
by: Setu Mittal, et al.
Published: (2023-01-01)
Generalized pustular psoriasis in a toddler with IL36RN mutation: a case report
by: Ghaith Adi, et al.
Published: (2024-03-01)
by: Ghaith Adi, et al.
Published: (2024-03-01)
Successful Treatment of Pediatric Generalized Pustular Psoriasis (GPP) with Spesolimab: 5 Case Reports and Evaluations of Circulating IL-36 Levels
by: Chen Y, et al.
Published: (2024-11-01)
by: Chen Y, et al.
Published: (2024-11-01)
Atezolizumab-Induced Acrodermatitis and Pustular Psoriasis in a Patient with Non-Small Cell Lung Cancer: A Rare Case Report
by: Davide Fattore, et al.
Published: (2024-02-01)
by: Davide Fattore, et al.
Published: (2024-02-01)
Hereditary acrodermatitis enteropathica: A case report
by: LI Jibing, et al.
Published: (2024-09-01)
by: LI Jibing, et al.
Published: (2024-09-01)
Efficacy and Safety of Bimekizumab in Japanese Patients with Generalised Pustular Psoriasis and Erythrodermic Psoriasis: 3-Year Results from BE BRIGHT, a Multicentre, Open-Label, Phase 3 Study
by: Yukari Okubo, et al.
Published: (2025-08-01)
by: Yukari Okubo, et al.
Published: (2025-08-01)
Acrodermatitis dysmetabolica secondary to isoleucine deficiency in infant with maple syrup urine disease
by: Fares A. Alkhayal, et al.
Published: (2023-08-01)
by: Fares A. Alkhayal, et al.
Published: (2023-08-01)
Acquired acrodermatitis enteropathica after abdominal surgery: Case report
by: Adriana Giraldo-Villa, et al.
Published: (2019-07-01)
by: Adriana Giraldo-Villa, et al.
Published: (2019-07-01)
Serious generalized pustular psoriasis with evolution to plaque psoriasis: approach with spesolimab
by: Liz S. Gea, et al.
Published: (2024-10-01)
by: Liz S. Gea, et al.
Published: (2024-10-01)
An Acrodermatitis Enteropathica Case
by: Sevda Önder, et al.
Published: (2019-04-01)
by: Sevda Önder, et al.
Published: (2019-04-01)
Acrodermatitis dysmetabolica with concomitant acquired acrodermatitis enteropathica in a patient with maple syrup urine disease
by: Luis E. Santaliz-Ruiz, IV, MD, et al.
Published: (2024-03-01)
by: Luis E. Santaliz-Ruiz, IV, MD, et al.
Published: (2024-03-01)
Zinc Supplementation for Acrodermatitis Enteropathica Overlapped with Psoriasiform Lesions
by: Wang L, et al.
Published: (2024-11-01)
by: Wang L, et al.
Published: (2024-11-01)
New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors
by: João Vilaça, et al.
Published: (2024-07-01)
by: João Vilaça, et al.
Published: (2024-07-01)
Management of Pustular Psoriasis; The Way Ahead
by: Shrichand G. Parasramani, et al.
Published: (2024-06-01)
by: Shrichand G. Parasramani, et al.
Published: (2024-06-01)
Economic Burden of Generalized Pustular Psoriasis in Sweden: A Population-Based Register Study
by: Löfvendahl S, et al.
Published: (2022-05-01)
by: Löfvendahl S, et al.
Published: (2022-05-01)
Exploring Zinc Metabolism Disorders: A Case Series of Acrodermatitis Enteropathica
by: Harsh Tyagi, et al.
Published: (2025-07-01)
by: Harsh Tyagi, et al.
Published: (2025-07-01)
Similar Items
-
Case report: Successful treatment with spesolimab of acrodermatitis continua of Hallopeau in an older patient without IL36RN mutations
by: Jianfeng Zheng, et al.
Published: (2025-01-01) -
Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report
by: Pengfei Wen, et al.
Published: (2024-02-01) -
Spesolimab in generalized pustular psoriasis complicated by acrodermatitis continua of Hallopeau: a case report and mechanistic insights
by: Xin-Yi Hou, et al.
Published: (2025-05-01) -
Long-term control of refractory acrodermatitis continua of Hallopeau with subcutaneous spesolimab: A case report
by: Jan Nicolai Wagner, MD, et al.
Published: (2025-12-01) -
Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report
by: May Alorainy, et al.
Published: (2017-12-01)
